Literature DB >> 18770073

Entrapment of ovalbumin into liposomes--factors affecting entrapment efficiency, liposome size, and zeta potential.

Marija Brgles1, Darija Jurasin, Maja Dutour Sikirić, Ruza Frkanec, Jelka Tomasić.   

Abstract

Various amounts of Ovalbumin (OVA) were encapsulated into positively and negatively charged multilamellar liposomes, with the aim to investigate the entrapment efficiency in different buffers and to study their effects on the liposome size and zeta potential. Results showed that the entrapment efficiency of OVA in anionic liposomes was the same in 10 mM Phosphate Buffer (PB) as in Phosphate-Buffered Saline (PBS; PB + 0.15 M NaCl). Also, liposome size was approximately 1200 nm for all anionic liposomes incorporating OVA. The entrapment efficiency of OVA in cationic liposomes was highly dependent on ionic strength. The size of cationic liposomes was approximately 1200 nm in PBS, regardless of protein content, but increased with the amount of the incorporated protein in PB. Aggregation of cationic liposomes in PB was observed when the mass of the protein was 2.5 mg or greater. The zeta potential of anionic liposomes was negative and of cationic liposomes positive in the whole range of protein mass tested. These results show how different compositions of lipid and aqueous phases can be used to vary the entrapment efficiency, liposome size, and zeta potential--the factors that are of great importance for the use of liposomes as drug carriers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18770073     DOI: 10.1080/08982100802312762

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  9 in total

1.  Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol.

Authors:  Qingxia Guan; Shuang Sun; Xiuyan Li; Shaowa Lv; Ting Xu; Jialin Sun; Wenjing Feng; Liang Zhang; Yongji Li
Journal:  J Mater Sci Mater Med       Date:  2015-12-24       Impact factor: 3.896

2.  Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies.

Authors:  Sara Nageeb El-Helaly; Ahmed Abd Elbary; Mohamed A Kassem; Mohamed A El-Nabarawi
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Development and characterization of polymer-coated liposomes for vaginal delivery of sildenafil citrate.

Authors:  Hanan Refai; Doaa Hassan; Rehab Abdelmonem
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin.

Authors:  Kunchi Zhang; Shaowa Lv; Xiuyan Li; Yufei Feng; Xin Li; Lu Liu; Shuang Li; Yongji Li
Journal:  Int J Nanomedicine       Date:  2013-08-22

5.  Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route.

Authors:  Pratik Upadhyay; Jatin Trivedi; Kilambi Pundarikakshudu; Navin Sheth
Journal:  Saudi Pharm J       Date:  2016-08-05       Impact factor: 4.330

6.  Long wavelength single photon like driven photolysis via triplet triplet annihilation.

Authors:  Ling Huang; Le Zeng; Yongzhi Chen; Nuo Yu; Lei Wang; Kai Huang; Yang Zhao; Gang Han
Journal:  Nat Commun       Date:  2021-01-05       Impact factor: 14.919

7.  Enzymatic enhancing of triplet-triplet annihilation upconversion by breaking oxygen quenching for background-free biological sensing.

Authors:  Ling Huang; Timmy Le; Kai Huang; Gang Han
Journal:  Nat Commun       Date:  2021-03-26       Impact factor: 14.919

Review 8.  When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications.

Authors:  Kazuaki Taguchi; Yuko Okamoto; Kazuaki Matsumoto; Masaki Otagiri; Victor Tuan Giam Chuang
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-26

9.  Electrostatically Driven Encapsulation of Hydrophilic, Non-Conformational Peptide Epitopes into Liposomes.

Authors:  Ehsan Suleiman; Dominik Damm; Mirjam Batzoni; Vladimir Temchura; Andreas Wagner; Klaus Überla; Karola Vorauer-Uhl
Journal:  Pharmaceutics       Date:  2019-11-18       Impact factor: 6.525

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.